(redirected from ceftazidime)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
Related to ceftazidime: ceftriaxone, Cefepime, cefotaxime, ciprofloxacin
See: drug
References in periodicals archive ?
As per the criteria, 100 Gram-negative bacteria which were resistant to cefotaxime, ceftazidime and ceftriaxone obtained from various clinical specimens were tested for the presence of AmpC.
Phenotypic confirmatory test of provisional ESBLs producers was carried out by combined disk method by using antimicrobial disks of Ceftazidime (30g) and Cefotaxime (30g) alone and in combination with Cla-vulanic acid (30/10g) on Mueller Hinton agar plates.
aeruginosa the values of MIC obtained by agar dilution were in range of 64-1024, 32-128, 16-256, 16-256, and 16-32 ug/ml for ceftazidime, amikacin, meropenem, tazocin and ciprofloxacin, respectively versus the MIC values obtained by broth microdilution as 32-1024, 16-128, 8-256, 16-256, and 16-32 ug/ml for ceftazidime, amikacin, meropenem, tazocin and ciprofloxacin, respectively.
For bacteria isolated from diabetic foot infection, the following antibiotics were used against the causative agents: amikacin (30ug), (20ug of amoxicillin + 10ug of clavulanate), cefotaxime (30ug), ceftazidime (30ug), ciprofloxacin (5ug), erythromycin (15ug), gentamycin (10ug), oxacillin (1ug), piperacillin (100ug) and vancomycin (30ug).
Enhancement effect of ZnO nanoparticles on ceftazidime activity was studied by turbidity measurement using ELISA reader (Authos 2020-Austria).
diameter zone of [less than or equal to] 22mm with ceftazidime, [less than or equal to] 27mm with aztreonam, [less than or equal to] 27mm with cefotaxime, and [less than or equal to] 25mm with ceftriaxone were considered potential ESBL produces and further proceeded for confirmation (6).
During the next 2 days, the chicken was hospitalized and received ceftazidime (20 mg/kg q12h, with a saline flush before and after the infusion, and the VAP was locked with 2 mL of heparin-saline after the second flush.
For each sample, 1 disk contained cefotaxime, ceftazidime, or cefepime, and a second disk contained ticarcillin and clavulanate (10).
It consists of ceftazidime, a third-generation, antipseudomonal cephalosporin, that is an established treatment for serious Gram-negative bacterial infections, and avibactam, a next generation, non-beta lactam beta-lactamase inhibitor.
The inoculum effects noted in this study with ceftazidime-avibactam MICs are not surprising given that inoculum effects have been previously documented with ceftazidime MIC testing, particularly against [beta]-lactamase producing strains [5-7].
Ceftazidime 30 [micro]g, cefotaxime 30|ig and an amoxicillin/clavulanic acid 20+ 10 [micro]g were placed at a distance of 25-30 mm apart, centre to centre.